Ultralife Corporation
ULBI
$6.13
-$0.25-3.92%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 191.16M | 186.53M | 178.85M | 173.28M | 164.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 191.16M | 186.53M | 178.85M | 173.28M | 164.46M |
| Cost of Revenue | 145.06M | 141.89M | 135.15M | 129.63M | 122.14M |
| Gross Profit | 46.10M | 44.64M | 43.71M | 43.65M | 42.31M |
| SG&A Expenses | 31.90M | 29.15M | 27.85M | 26.61M | 25.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 187.36M | 181.03M | 172.23M | 165.15M | 155.85M |
| Operating Income | 3.80M | 5.50M | 6.62M | 8.13M | 8.60M |
| Income Before Tax | -8.40M | 2.30M | 4.41M | 7.14M | 8.30M |
| Income Tax Expenses | -2.45M | 568.00K | 1.15M | 1.76M | 1.89M |
| Earnings from Continuing Operations | -5.95 | 1.74 | 3.26 | 5.38 | 6.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 53.00K | -17.00K | -65.00K | -98.00K | -97.00K |
| Net Income | -5.90M | 1.72M | 3.20M | 5.29M | 6.31M |
| EBIT | 3.80M | 5.50M | 6.62M | 8.13M | 8.60M |
| EBITDA | 9.30M | 10.87M | 11.57M | 12.67M | 12.76M |
| EPS Basic | -0.35 | 0.10 | 0.19 | 0.32 | 0.38 |
| Normalized Basic EPS | 0.05 | 0.06 | 0.12 | 0.22 | 0.26 |
| EPS Diluted | -0.36 | 0.10 | 0.19 | 0.32 | 0.38 |
| Normalized Diluted EPS | 0.05 | 0.06 | 0.12 | 0.22 | 0.25 |
| Average Basic Shares Outstanding | 66.57M | 66.54M | 66.52M | 66.46M | 66.22M |
| Average Diluted Shares Outstanding | 66.64M | 66.74M | 66.97M | 67.14M | 66.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |